Cargando…
Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients’ Sera
The robustness, safety, versatility, and high immunogenicity of virus-like particles (VLPs) make them a promising approach for the generation of vaccines against a broad range of pathogens. VLPs are recombinant macromolecular structures that closely mimic the native conformation of viruses without c...
Autores principales: | Boix-Besora, Arnau, Gòdia, Francesc, Cervera, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675557/ https://www.ncbi.nlm.nih.gov/pubmed/38005972 http://dx.doi.org/10.3390/vaccines11111641 |
Ejemplares similares
-
Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2
por: Boix-Besora, Arnau, et al.
Publicado: (2022) -
Characterization and quantitation of fluorescent Gag virus-like particles
por: Gutiérrez-Granados, Sonia, et al.
Publicado: (2013) -
Differential N‐ and O‐glycosylation signatures of HIV‐1 Gag virus‐like particles and coproduced extracellular vesicles
por: Lavado‐García, Jesús, et al.
Publicado: (2022) -
A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles
por: González-Domínguez, Irene, et al.
Publicado: (2021) -
An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures
por: Lavado-García, Jesús, et al.
Publicado: (2020)